Healthcare Equipment and Supplies
Company Overview of Debiotech S.A.
Debiotech S.A. engages in the research and development of medical devices for therapeutic and diagnostic purposes. The company offers electronic infusion systems, drug delivery devices, microsystems, and diagnostics products. Its products include disposable programmable micro pumps, miniaturized infusion pumps, contrast media injectors, drug reconstitution devices, cyclers for peritoneal dialysis, flow regulators, and nano delivery systems. The company offers its products through medical devices and pharmaceutical companies. Debiotech S.A. was founded in 1990 and is based in Lausanne, Switzerland.
Avenue de Sévelin 28
Founded in 1990
Key Executives for Debiotech S.A.
Chief Executive Officer, President and Managing Director
Compensation as of Fiscal Year 2015.
Debiotech S.A. Key Developments
Debiotech to Introduce New Insulin JewelPUMP2 for Diabetes Type 2 During the 2014 ATTD Conference in Vienna, Austria
Jan 29 14
Debiotech S.A. announced that JewelPUMP2, which will be unveiled for the first time at the ATTD 2014 congress on February 5(th) in Vienna, is a new product dedicated to the Diabetes Type 2 market, based on Debiotech's innovative JewelPUMP platform. The JewelPUMP2 has been entirely re-designed to address the very specific market of Type 2 patients, requiring an extremely simple to use and very convenient and secured insulin delivery patch. By using its JewelPUMP platform, which is already in the industrialization phase and in preparation for the CE marking, Debiotech will be able to introduce the JewelPUMP2 shortly after its JewelPUMP for Type 1 patients, while ensuring the same degree of miniaturization, safety and reliability. The JewelPUMP2 is opening entirely new possibilities for Diabetic Type 2 patients, including improved convenience of use, very easy programming with simplified basal-bolus selection and automatic Meal correction, as well as real-time remote communication and assistance to assist in proper treatment compliance.
Debiotech S.A. and AWAK Technologies Pte Ltd Enter into Joint Agreement for the Development and Manufacturing of a Novel Miniaturized Home Hemodialysis Machine
Oct 31 13
Debiotech SA, Switzerland, and AWAK Technologies Pte Ltd. announced that they have entered into a partnership agreement regarding the development and manufacturing of a novel miniaturized Home Hemodialysis machine intended to serve the growing need for homecare treatment of patients suffering from end-stage renal disease. This new system will be based on Debiotech's highly miniaturized Home dialysis equipment 'DialEase([TM])', developed for Home Peritoneal dialysis, and AWAK's novel sorbent technology for fluid purification. The combination of both companies' product expertise will lead to a new system which shall be extremely small and convenient to use, less intrusive in a patient's life and more cost effective. This new system will also require much less fluid than conventional Hemodialysis machines and will be monitored in real time from the hospital via the cloud.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries